Annual Short Term Debt
$410.00 K
-$77.00 M-99.47%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual short term debt is currently $410.00 thousand, with the most recent change of -$77.00 million (-99.47%) on 31 December 2023. During the last 3 years, it has fallen by -$8.07 million (-95.16%). LGND annual short term debt is now -99.82% below its all-time high of $224.53 million, reached on 31 December 2017.LGND Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.09 M
-$78.00 K-6.68%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly short term debt is currently $1.09 million, with the most recent change of -$78.00 thousand (-6.68%) on 30 September 2024. Over the past year, it has increased by +$593.00 thousand (+119.32%). LGND quarterly short term debt is now -99.52% below its all-time high of $227.55 million, reached on 31 March 2018.LGND Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -99.5% | +119.3% |
3 y3 years | -95.2% | -51.0% |
5 y5 years | -98.5% | +17.7% |
LGND Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -99.5% | at low | -99.1% | +165.8% |
5 y | 5 years | -99.5% | at low | -99.1% | +165.8% |
alltime | all time | -99.8% | -99.5% |
Ligand Pharmaceuticals Incorporated Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.09 M(-6.7%) |
June 2024 | - | $1.17 M(+16.5%) |
Mar 2024 | - | $1.00 M(+144.6%) |
Dec 2023 | $410.00 K(-99.5%) | $410.00 K(-17.5%) |
Sept 2023 | - | $497.00 K(-26.9%) |
June 2023 | - | $680.00 K(-99.1%) |
Mar 2023 | - | $77.49 M(+0.1%) |
Dec 2022 | $77.41 M(+5378.4%) | $77.41 M(-2.0%) |
Sept 2022 | - | $78.99 M(-32.8%) |
June 2022 | - | $117.53 M(+6079.0%) |
Mar 2022 | - | $1.90 M(+34.6%) |
Dec 2021 | $1.41 M(-83.3%) | $1.41 M(-36.5%) |
Sept 2021 | - | $2.23 M(-4.1%) |
June 2021 | - | $2.32 M(-69.5%) |
Mar 2021 | - | $7.61 M(-10.2%) |
Dec 2020 | $8.48 M(+575.5%) | $8.48 M(+723.9%) |
Sept 2020 | - | $1.03 M(-40.5%) |
June 2020 | - | $1.73 M(+16.5%) |
Mar 2020 | - | $1.48 M(+18.2%) |
Dec 2019 | $1.25 M(-95.3%) | $1.25 M(+35.5%) |
Sept 2019 | - | $926.00 K(-96.7%) |
June 2019 | - | $28.08 M(+0.5%) |
Mar 2019 | - | $27.94 M(+5.7%) |
Dec 2018 | $26.43 M(-88.2%) | $26.43 M(-87.6%) |
Sept 2018 | - | $213.14 M(+1.3%) |
June 2018 | - | $210.37 M(-7.5%) |
Mar 2018 | - | $227.55 M(+1.3%) |
Dec 2017 | $224.53 M(+5.5%) | $224.53 M(+1.3%) |
Sept 2017 | - | $221.56 M(+1.3%) |
June 2017 | - | $218.63 M(+1.3%) |
Mar 2017 | - | $215.75 M(+1.3%) |
Dec 2016 | $212.91 M(+5.4%) | $212.91 M(+1.3%) |
Sept 2016 | - | $210.12 M(+1.3%) |
June 2016 | - | $207.36 M(+2.7%) |
Dec 2015 | $201.99 M(+2117.4%) | $201.99 M(>+9900.0%) |
Mar 2015 | - | $348.00 K(+3.3%) |
Sept 2014 | - | $337.00 K(-87.5%) |
June 2014 | - | $2.70 M(-53.2%) |
Mar 2014 | - | $5.77 M(-36.7%) |
Dec 2013 | $9.11 M(-38.6%) | $9.11 M(-26.4%) |
Sept 2013 | - | $12.38 M(-9.0%) |
June 2013 | - | $13.60 M(+2.9%) |
Mar 2013 | - | $13.21 M(-10.9%) |
Dec 2012 | $14.84 M(+48.4%) | $14.84 M(+11.9%) |
Sept 2012 | - | $13.26 M(-13.3%) |
June 2012 | - | $15.29 M(+150.9%) |
Mar 2012 | - | $6.10 M(-39.0%) |
Dec 2011 | $10.00 M(>+9900.0%) | $10.00 M(-44.5%) |
Sept 2011 | - | $18.03 M(+80.3%) |
June 2011 | - | $10.00 M(-2.9%) |
Mar 2011 | - | $10.30 M(>+9900.0%) |
Dec 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2010 | - | $15.07 M(-23.1%) |
June 2010 | - | $19.60 M(+328.6%) |
Mar 2010 | - | $4.57 M(-62.2%) |
Sept 2009 | - | $12.10 M(+2.9%) |
June 2009 | - | $11.76 M(+1.8%) |
Mar 2009 | - | $11.55 M(+531.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2008 | $1.83 M(+19.7%) | $1.83 M(+155.4%) |
Sept 2008 | - | $716.00 K(-26.8%) |
June 2008 | - | $978.00 K(-21.0%) |
Mar 2008 | - | $1.24 M(-19.0%) |
Dec 2007 | $1.53 M(-96.2%) | $1.53 M(-15.6%) |
Sept 2007 | - | $1.81 M(-9.0%) |
June 2007 | - | $1.99 M(-7.5%) |
Mar 2007 | - | $2.15 M(-94.6%) |
Dec 2006 | $39.92 M(+1354.2%) | $39.92 M(>+9900.0%) |
Sept 2006 | - | $363.00 K(-85.5%) |
June 2006 | - | $2.50 M(-5.5%) |
Mar 2006 | - | $2.65 M(-3.5%) |
Dec 2005 | $2.75 M(-6.1%) | $2.75 M(-2.8%) |
Sept 2005 | - | $2.83 M(-4.9%) |
June 2005 | - | $2.97 M(-0.2%) |
Mar 2005 | - | $2.98 M(+1.8%) |
Dec 2004 | $2.92 M(+18.0%) | $2.92 M(-0.2%) |
Sept 2004 | - | $2.93 M(+6.3%) |
June 2004 | - | $2.76 M(+0.5%) |
Mar 2004 | - | $2.74 M(+10.6%) |
Dec 2003 | $2.48 M(+18.8%) | $2.48 M(-58.8%) |
June 2003 | - | $6.02 M(+185.8%) |
Mar 2003 | - | $2.10 M(+0.9%) |
Dec 2002 | $2.09 M(-61.1%) | $2.09 M(-76.6%) |
Sept 2002 | - | $8.91 M(+74.9%) |
June 2002 | - | $5.09 M(-90.4%) |
Mar 2002 | - | $53.13 M(+890.0%) |
Dec 2001 | $5.37 M(+54.3%) | $5.37 M(+110.4%) |
Sept 2001 | - | $2.55 M(-79.1%) |
June 2001 | - | $12.23 M(+309.4%) |
Mar 2001 | - | $2.99 M(-14.1%) |
Dec 2000 | $3.48 M(-15.2%) | $3.48 M(-10.8%) |
Sept 2000 | - | $3.90 M(-8.2%) |
June 2000 | - | $4.25 M(+0.6%) |
Mar 2000 | - | $4.22 M(+3.0%) |
Dec 1999 | $4.10 M(+28.1%) | $4.10 M(+10.8%) |
Sept 1999 | - | $3.70 M(+5.7%) |
June 1999 | - | $3.50 M(+6.1%) |
Mar 1999 | - | $3.30 M(+3.1%) |
Dec 1998 | $3.20 M(+14.3%) | $3.20 M(+3.2%) |
Sept 1998 | - | $3.10 M(+10.7%) |
June 1998 | - | $2.80 M(+3.7%) |
Mar 1998 | - | $2.70 M(-3.6%) |
Dec 1997 | $2.80 M(+7.7%) | $2.80 M(-3.4%) |
Sept 1997 | - | $2.90 M(0.0%) |
June 1997 | - | $2.90 M(+3.6%) |
Mar 1997 | - | $2.80 M(+7.7%) |
Dec 1996 | $2.60 M(+8.3%) | $2.60 M(-3.7%) |
Sept 1996 | - | $2.70 M(+3.8%) |
June 1996 | - | $2.60 M(-3.7%) |
Mar 1996 | - | $2.70 M(+12.5%) |
Dec 1995 | $2.40 M(+84.6%) | $2.40 M(+84.6%) |
Sept 1995 | - | $1.30 M(0.0%) |
Mar 1995 | - | $1.30 M(0.0%) |
Dec 1994 | $1.30 M | $1.30 M(+8.3%) |
Sept 1994 | - | $1.20 M(0.0%) |
June 1994 | - | $1.20 M(0.0%) |
Mar 1994 | - | $1.20 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual short term debt?
- What is the all time high annual short term debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual short term debt year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly short term debt?
- What is the all time high quarterly short term debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly short term debt year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual short term debt?
The current annual short term debt of LGND is $410.00 K
What is the all time high annual short term debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual short term debt is $224.53 M
What is Ligand Pharmaceuticals Incorporated annual short term debt year-on-year change?
Over the past year, LGND annual short term debt has changed by -$77.00 M (-99.47%)
What is Ligand Pharmaceuticals Incorporated quarterly short term debt?
The current quarterly short term debt of LGND is $1.09 M
What is the all time high quarterly short term debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly short term debt is $227.55 M
What is Ligand Pharmaceuticals Incorporated quarterly short term debt year-on-year change?
Over the past year, LGND quarterly short term debt has changed by +$593.00 K (+119.32%)